Back

prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with or without peripheral arterial disease.

30 August 2016 (12:12 - 12:21)
Organised by:
Congress Presentation Part of: What's hot in PCI PCI: primary PCI / patient subsets ESC Premium Access ESC Congress 2016

About the speaker

Photo
Associate Professor Anna Franzone

University of Naples Federico II, Naples (Italy)

9 More presentations in this session

Presentation thumbnail
Clinical outcomes of re-attempt percutaneous coronary intervention for chronic total occlusion: subanalysis from Japanese Retrograde Summit Registry
Doctor M. Tanabe (Kyoto, JP)
Abstract
Presentation thumbnail
Low-dose exposure to ionizing radiation deregulates the brain specific miRNA-134 in interventional cardiologists
Doctor A. Borghini (Pisa, IT)
Abstract
Presentation thumbnail
Predictive value of five different risk scores for 30-day and 4-year mortality of patients with acute ST-elevation myocardial infarction undergoing primary PCI
Doctor Z. Mehmedbegovic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Coronary artery bypass graft surgery versus percutaneous coronary intervention for isolated left main-stem disease: a real world contemporary analysis of 2,662 patients
Doctor C. Ilsley (Harefield Hospital, GB)
Abstract Slides Video
Presentation thumbnail
Routine aspiration thrombectomy is associated with increased stroke rates during primary percutaneous coronary intervention for myocardial infarction
Doctor R. Perera (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
What's hot in PCI

The Event

Event poster

ESC Congress 2016

30 August 2016 12:12 CET
You may be interested in
thumbnail
Congress Presentation
Intense antithrombotic therapy is necessary for long-term treatment in patients with symptomatic peripheral artery disease after acute myocardial infarction and primary PCI
28 August 2020
thumbnail
Congress Presentation
Choice of monotherapy following short duration of dual-antiplatelet therapy after percutaneous coronary intervention: a meta-analysis of randomized clinical trials
31 August 2025
thumbnail
Congress Presentation
Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients (LEGACY)
1 September 2025
thumbnail
Congress Presentation
Thirty-days versus standard duration of dual antiplatelet treatment after percutaneous coronary interventions: a systematic review and meta-analysis
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources